Prescription medications carry risks and side effects. A licensed physician will review your health history before prescribing. Prescriptions are never guaranteed. Individual results vary.
Highest Efficacy · Most Results
GLP-1 + GIP Weight Loss

Tirze-
patide

NuvaMed physicians prescribe FDA-approved GLP-1 + GIP medications, including tirzepatide (Zepbound®), when clinically appropriate
20.9%Avg body weight lost
91%Patient success rate
WeeklyInjection schedule
Start for $299/month →
Physician evaluation included · No insurance needed
Tirzepatide prefilled autoinjector
Licensed Physicians FDA-Approved Medications Licensed U.S. Pharmacies HIPAA Compliant
Why Tirzepatide Is Different

Two hormones. Superior results.

Tirzepatide is the first medication to target two different metabolic hormones simultaneously — GLP-1 and GIP. This dual action is why it consistently outperforms every other weight loss medication in clinical trials.

GLP-1 Receptor
Appetite & Satiety
The GLP-1 component suppresses appetite, slows gastric emptying, and signals the brain that you're full — the same mechanism as semaglutide.
−15%
GLP-1 alone avg weight loss
GIP Receptor (tirzepatide exclusive)
Fat Burning Amplified
The GIP component works synergistically with GLP-1 to enhance fat metabolism, reduce fat storage, and improve insulin sensitivity — effects GLP-1 alone cannot achieve.
+6%
Additional loss from GIP action
Clinical Trial Data

The SURMOUNT results

The SURMOUNT-1 trial enrolled 2,539 patients. At 72 weeks on tirzepatide 15mg, patients lost an average of 20.9% body weight — with one-third of patients losing more than 25% of their body weight.

Tirzepatide 15mg (SURMOUNT-1)−20.9%
Tirzepatide 10mg−19.5%
Semaglutide 2.4mg (comparison)−15%
91% of patients lost ≥5% body weight91%

Source: Jastreboff AM et al. N Engl J Med. 2022;387:205-216. (SURMOUNT-1 Trial)

Treatment Schedule

Your titration schedule

Tirzepatide is started at 2.5mg weekly and increased every 4 weeks. Most patients reach their target dose within 5–6 months, with meaningful weight loss beginning at month 2.

MonthWeekly DoseWhat to Expect
Month 12.5mg/weekMild appetite reduction. Gastrointestinal adjustment period.
Month 25mg/weekNoticeably less hunger. First weight loss visible (typically 4–8 lbs).
Month 37.5mg/weekSignificant appetite suppression. Accelerating results.
Month 410mg/weekConsistent weight loss. Energy improving. Cravings greatly reduced.
Month 512.5mg/weekApproaching full efficacy. Substantial results visible.
Month 6+15mg/week (max dose)Full therapeutic dose. Sustained weight loss toward long-term goal.
Safety Profile

Side effects & safety

Tirzepatide has a safety profile similar to other GLP-1 medications. Side effects are predominantly gastrointestinal, mostly during dose increases, and resolve over time.

Common (usually temporary)
  • Nausea (most common, typically decreases within 4 weeks)
  • Diarrhea or constipation
  • Vomiting (less common than nausea)
  • Fatigue during titration
  • Decreased appetite (intended effect)
Uncommon / Rare
  • Pancreatitis (rare — physician will screen)
  • Gallbladder disease (pre-existing risk)
  • Not recommended in pregnancy
  • Contraindicated with personal/family thyroid cancer history
  • Injection site reactions (mild, transient)

Your NuvaMed physician will conduct a thorough health review before prescribing and monitor your progress throughout treatment.

Comparison

Tirzepatide vs Semaglutide

TirzepatideSemaglutide
Brand equivalentMounjaro® / Zepbound®Ozempic® / Wegovy®
MechanismGLP-1 + GIP dual agonistGLP-1 agonist only
Avg weight loss~21%~15%
Clinical success rate91%83%
Best for BMI30+ (obese)27–30 (overweight)
Years of safety data3 years5+ years
NuvaMed price$299/month$249/month
Transparent Pricing

What you pay — shown upfront

Your NuvaMed membership covers physician visit, ongoing clinical care, care-team messaging, and treatment management. Medication is dispensed by a licensed pharmacy; your total monthly cost is shown in full before you pay anything. You are not charged unless a physician approves treatment.

GLP-1 + GIP Weight Loss
Ask at assessment
Total cost shown before payment

Cancel anytime from your patient portal. No phone calls, no cancellation fees.

Common Questions

Tirzepatide FAQs

NuvaMed physicians prescribe FDA-approved GLP-1 + GIP medications — including tirzepatide (Zepbound®) — when clinically appropriate. Your physician selects the medication and dose based on your health history. Zepbound® is a trademark of Eli Lilly. NuvaMed is not affiliated with or endorsed by Eli Lilly.
Tirzepatide activates both GLP-1 and GIP receptors, a dual mechanism that in clinical trials produced greater average weight loss (~21%) than GLP-1-only medications like semaglutide (~15%).
Tirzepatide has 3+ years of clinical safety data. Your physician monitors your progress and adjusts your dose throughout treatment to manage any side effects.
Your physician can adjust your treatment plan, including switching between semaglutide and tirzepatide, based on your response and tolerance. Contact your care team through the patient portal.
Yes. You can cancel or pause your subscription anytime from your patient portal or by emailing help@nuvamed.org.
Get Started

Start your tirzepatide program

The most effective weight loss medication available. A licensed physician will evaluate your profile and prescribe the right dose — medication delivered to your door.

✓ 30-Day Money-Back Guarantee
✓ HSA / FSA Accepted
Tirzepatide Program · Starting at
$299/month
Begin My Intake →
Physician evaluation included · No insurance required · Cancel anytime
Stay Informed
Get your GLP-1 readiness guide
Enter your email and we'll send you a free guide on physician-supervised weight loss — what to expect, how to qualify, and how to get started.
Ready to get started? Free assessment — takes 5 minutes.
Get My Plan →